Track Aerovate Therapeutics Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Aerovate Therapeutics Inc. Common Stock AVTE · Stock Open Aerovate Therapeutics Inc. Common Stock in new tab

2.68 USD
EPS
-2.44
Yield
89.55%
Safety Score
2
P/B
1.05
ROE
-74.91
Beta
0.95
Target Price
2.33 USD
Loading chart...
Key Metrics
EPS-2.44
Book Value2.64
Price to Book1.05
Debt/Equity0.55
% Insiders0.017%
Estimates
Forward P/E-2.76
Forward EPS-1.00
Target Mean Price2.33
Dividend
Dividend Yield89.55%
Annual dividends2.40 USD
Ex-Div. DateApril 29, 2025

DCF valuation

Model fair value for Aerovate Therapeutics Inc. Common Stock (AVTE)
Result
Sign in to run the valuation for AVTE.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
mean target 2.33 USD (low 2.00, high 3.00)
Low 2.00
Mean 2.33
High 3.00
Price 2.68
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Aerovate Therapeutics Inc. Common Stock Logo Aerovate Therapeutics Inc. Common Stock Analysis (AVTE)

United States Health Care Official Website Stock

Is Aerovate Therapeutics Inc. Common Stock a good investment? Aerovate Therapeutics Inc. Common Stock (AVTE) is currently trading at 2.68 USD. Market analysts have a consensus price target of 2.33 USD. This suggests the asset is currently trading above analyst expectations.

For income investors, Aerovate Therapeutics Inc. Common Stock pays a dividend yield of 89.55%.

Investor FAQ

Does Aerovate Therapeutics Inc. Common Stock pay a dividend?

Yes, it pays an annual dividend of 2.40 USD (89.55% yield).

What asset class is Aerovate Therapeutics Inc. Common Stock?

Aerovate Therapeutics Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Aerovate Therapeutics, Inc., a biopharmaceutical company, engages in the treatment of pulmonary arterial hypertension in the United States. Aerovate Therapeutics, Inc., was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Exchange Ticker
NMS (United States) AVTE
Trades
Dividend Yield
89.55%
Annual Dividends
2.40USD
Next Ex. Div Date
April 29, 2025
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2025
2.40 USD
April 28, 2025 2.4000
Stock Splits
Split Date Split Ratio to 1
April 29, 2025 0.03
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion